Abstract
Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R.sup.1 is a linear or branched C.sub.9-C.sub.33 alkyl or a linear or branched C.sub.9-C.sub.33 alkenyl with 1 to 4 double bonds; R.sup.2 is a linear or branched C.sub.9-C.sub.19 alkyl or a linear or branched C.sub.9-C.sub.19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.
Original language | English |
---|---|
Patent number | US20200190015A1 |
Filing date | 18/07/19 |
Publication status | Published - 2020 |